Re: 'response to letter to the editor on "Galectin-3, carotid plaque vulnerability, and potential effects of statin therapy"'

Eur J Vasc Endovasc Surg. 2015 May;49(5):613-4. doi: 10.1016/j.ejvs.2015.02.010. Epub 2015 Mar 14.

Authors

N P Kadoglou¹, G S Sfyroeras², A Spathis³, C Gkekas², A Gastounioti⁴, G Mantas², K S Nikita⁴, P Karakitsos³, C D Liapis²

Affiliations

¹ Department of Vascular Surgery, Medical School, University of Athens, Athens, Greece. Electronic address: nikoskad@yahoo.com.
² Department of Vascular Surgery, Medical School, University of Athens, Athens, Greece.
³ Department of Cytopathology, "Attikon" University Hospital, Athens, Greece.
⁴ School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece.

PMID: 25784505
DOI: 10.1016/j.ejvs.2015.02.010

No abstract available

Publication types

Letter
Comment

MeSH terms

Carotid Artery Diseases / pathology*
Carotid Artery Diseases / therapy*
Female
Galectin 3 / analysis*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
Male
Plaque, Atherosclerotic / chemistry*

Substances

Galectin 3
Hydroxymethylglutaryl-CoA Reductase Inhibitors